AlzeCure Pharma (Interview): CEO Martin Jönsson on the historical NeuroRestore deal
1 juli, 13:40
1 juli, 13:40
AlzeCure’s CEO joins us to discuss the company’s newly announced USD2.2bn out-licensing and collaboration agreement with QuantumCell regarding the NeuroRestore platform.
1 juli, 13:40
AlzeCure’s CEO joins us to discuss the company’s newly announced USD2.2bn out-licensing and collaboration agreement with QuantumCell regarding the NeuroRestore platform.
Aktieanalys
Aktieanalys
1 DAG %
Senast
OMX Stockholm 30
0,42%
(vid stängning)
Stockholmsbörsen
31 juli, 17:53
Stockholmsbörsen stänger uppåt
Apple
31 juli, 14:50
Apple faller över 7% i förhandeln
OMX Stockholm 30
1 DAG %
Senast
3 246,92